AVIR Atea Pharmaceuticals, Inc. - common stock
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 12, 2026
$5.13
· of 52w range
· above low
· to high
$2.8452w low
$6.4552w high
Market Cap (MRQ)
$411M
P/E
-2.6
EPS
$-1.94
your badges
52W Range
$3–$6
Analyst Rating
BUY
Price Target
$9
P/E
-2.6
ROE
-49.5%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
AVIR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$5.13
Market Cap (MRQ)
$411M
P/E
-2.6
EPS
$-1.94
ROE
-49.5%
52W Range
$3–$6
AVIR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2020-12-31 → 2021-12-31
EPS$-1.942019-12-31 → 2025-12-31
Free Cash Flow·2020-12-31 → 2022-12-31
Net margin·2020-12-31 → 2021-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | AVIR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -2.65Y avg ≈-0.5 | ≈-0.5 | · | · | |
| P/B (MRQ) | 2.05Y avg ≈0.8 | ≈0.8 | 2.7 | Undervalued | |
| Price / Cash Flow | -3.05Y avg ≈-3.8 | ≈-3.8 | · | · | |
| Price / Tangible Book | 1.55Y avg ≈0.8 | ≈0.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | AVIR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -40.6%5Y avg ≈-19.0% | ≈-19.0% | -24.5% | Weak | |
| ROE | -49.5%5Y avg ≈-22.0% | ≈-22.0% | -27.7% | Weak | |
| ROIC | -63.2%5Y avg ≈-28.0% | ≈-28.0% | -26.7% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | AVIR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 8.15Y avg ≈20.1 | ≈20.1 | 7.9 | In line | |
| Quick Ratio | 2.45Y avg ≈6.8 | ≈6.8 | 2.7 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
1.7%
Next Report
Nov 10, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-0.41 | $-0.57 | 28.2% |
| March 31, 2026 | May 13, 2026 | $-0.57 | $-0.60 | 5.3% |
| Dec. 31, 2025 | $-0.57 | $-0.54 | -5.4% | |
| Sept. 30, 2025 | $-0.53 | $-0.45 | -18.1% | |
| June 30, 2025 | $-0.44 | $-0.42 | -3.9% | |
| March 31, 2025 | $-0.40 | $-0.42 | 4.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $351M | $49M | |
| R&D Expense | $148M | $144M | $114M | $82M | $167M | $38M | |
| SG&A Expense | $33M | $49M | $50M | $49M | $46M | $22M | |
| Operating Expenses | $181M | $193M | $164M | $131M | $213M | $60M | |
| Operating Income | $-181M | $-193M | $-164M | $-131M | $138M | $-11M | |
| Pretax Income | $-165M | $-167M | $-135M | $-119M | $139M | $-11M | |
| Income Tax | $-6M | $925.0K | $1M | $-4M | $17M | · | |
| Net Income | $-158M | $-168M | $-136M | $-116M | $121M | $-11M | |
| EPS (Basic) | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.46 | $-0.51 | |
| EPS (Diluted) | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.37 | $-0.51 | |
| Shares (Basic) | 81,495,352 | 84,264,715 | 83,389,750 | 83,245,385 | 82,820,037 | 21,592,441 | |
| Shares (Diluted) | 81,495,352 | 84,264,715 | 83,389,750 | 83,245,385 | 88,249,243 | 21,592,441 | |
| EBITDA | $-181M | $-193M | $-164M | $-131M | $138M | $-11M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $96M | $65M | $144M | $188M | $764M | $850M | |
| Prepaid Expense | $9M | $8M | $12M | $14M | $8M | $8M | |
| Current Assets | $311M | $462M | $590M | $661M | $772M | $863M | |
| PP&E (Net) | $457.0K | $873.0K | $1M | $2M | $23.0K | $48.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $184.0K | $180.0K | |
| Accum. Depreciation | $2M | $1M | $689.0K | $273.0K | $161.0K | $132.0K | |
| Other Non-current Assets | $3M | $197.0K | $1M | $1M | $466.0K | $107.0K | |
| Total Assets | $315M | $465M | $595M | $667M | $773M | $864M | |
| Accounts Payable | $13M | $4M | $4M | $3M | $5M | $60.0K | |
| Current Liabilities | $40M | $19M | $32M | $18M | $57M | $316M | |
| Capital Leases | $0 | $842.0K | $2M | $2M | · | · | |
| Other Non-current Liabilities | · | · | · | · | $6M | $36.0K | |
| Total Liabilities | $40M | $26M | $40M | $26M | $63M | $316M | |
| Common Stock | $78.0K | $84.0K | $83.0K | $83.0K | $83.0K | $82.0K | |
| Paid-in Capital | $798M | $803M | $751M | $701M | $654M | $613M | |
| Retained Earnings | $-523M | $-364M | $-196M | $-60M | $56M | $-65M | |
| AOCI | $174.0K | $233.0K | $207.0K | $-684.0K | · | · | |
| Stockholders' Equity | $275M | $439M | $555M | $641M | $710M | $548M | |
| Liabilities + Equity | $315M | $465M | $595M | $667M | $773M | $864M | |
| Shares Outstanding | 78,126,796 | 84,463,059 | 83,435,513 | 83,287,639 | 83,102,730 | 82,436,937 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $416.0K | $416.0K | $416.0K | $260.0K | $29.0K | $19.0K | |
| Stock-based Comp | $21M | $52M | $49M | $47M | $40M | $7M | |
| Deferred Tax | $-6M | $0 | · | · | · | $0 | |
| Operating Cash Flow | $-132M | $-135M | $-85M | $-121M | $-87M | $297M | |
| CapEx | · | · | · | $2M | $4.0K | $26.0K | |
| Investing Cash Flow | $189M | $56M | $40M | $-455M | $-4.0K | $-26.0K | |
| Stock Issued | · | · | · | · | $1M | $27.0K | |
| Stock Repurchased | $26M | $0 | · | · | · | · | |
| Net Stock Activity | $-26M | · | · | · | $1M | $27.0K | |
| Financing Cash Flow | $-26M | $267.0K | $257.0K | $370.0K | $1M | $532M | |
| Net Change in Cash | $31M | $-79M | $-45M | $-576M | $-86M | $828M | |
| Free Cash Flow | · | · | · | $-123M | $-87M | $297M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | 39.4% | -22.7% | |
| Net Margin | · | · | · | · | 34.5% | -22.5% | |
| Pretax Margin | · | · | · | · | 39.4% | · | |
| EBITDA Margin | · | · | · | · | 39.4% | -22.7% | |
| ROA | -40.6% | -31.8% | -21.6% | -16.1% | 14.8% | -2.5% | |
| ROE | -49.5% | -37.5% | -23.9% | -17.8% | 18.8% | -4.7% | |
| ROIC | -63.2% | -44.2% | -29.8% | -19.8% | 17.0% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 7.8 | 24.9 | 18.2 | 35.8 | 13.6 | 2.7 | |
| Quick Ratio | 2.4 | 3.5 | 4.4 | 10.2 | 13.4 | 2.7 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.4 | 0.1 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.53 | $5.20 | $6.65 | $7.69 | $8.54 | $6.65 | |
| Revenue / Share | · | · | · | · | $3.98 | · | |
| Cash Flow / Share | $-1.62 | $-1.61 | $-1.02 | $-1.45 | $-0.99 | · | |
| Cash / Share | $1.23 | $0.77 | $1.72 | $2.26 | $9.20 | $10.31 | |
| EPS (TTM) | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.37 | $-0.51 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | · | 622.5% | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | $351M | $49M | |
| Net Income TTM | $-158M | $-168M | $-136M | $-116M | $121M | $-11M | |
| Market Cap | $279M | $283M | $254M | $401M | $743M | $3.44B | |
| P/E | -1.8 | -1.7 | -1.9 | -3.5 | 6.5 | -81.9 | |
| P/S | · | · | · | · | 2.1 | 70.8 | |
| P/B | 1.0 | 0.6 | 0.5 | 0.6 | 1.0 | 6.3 | |
| P / Tangible Book | 1.0 | 0.6 | 0.5 | 0.6 | 1.0 | 6.3 | |
| P / Cash Flow | -2.1 | -2.1 | -3.0 | -3.3 | -8.5 | 11.6 | |
| P / FCF | · | · | · | -3.3 | -8.5 | 11.6 | |
| Earnings Yield | -54.3% | -59.7% | -53.4% | -28.9% | 15.3% | -1.2% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $28M | $41M | $48M | $38M | $32M | $30M | $26M | $26M | $35M | $58M | $35M | $28M | $22M | $29M | $28M | $5M | |
| SG&A Expense | $7M | $7M | $7M | $7M | $9M | $9M | $13M | $11M | $12M | $12M | $12M | $13M | $13M | $13M | $12M | $11M | |
| Operating Expenses | $35M | $48M | $55M | $46M | $41M | $39M | $39M | $37M | $47M | $70M | $47M | $41M | $35M | $42M | $40M | $16M | |
| Operating Income | $-35M | $-48M | $-55M | $-46M | $-41M | $-39M | $-39M | $-37M | $-47M | $-70M | $-47M | $-41M | $-35M | $-42M | $-40M | $-16M | |
| Pretax Income | $-33M | $-45M | $-52M | $-42M | $-37M | $-34M | $-33M | $-31M | $-40M | $-63M | $-39M | $-33M | $-28M | $-35M | $-34M | $-12M | |
| Income Tax | $24.0K | $50.0K | $-7M | $196.0K | $207.0K | $203.0K | $225.0K | $226.0K | $243.0K | $231.0K | $349.0K | $221.0K | $251.0K | $197.0K | $123.0K | $-4M | |
| Net Income | $-33M | $-45M | $-45M | $-42M | $-37M | $-34M | $-34M | $-31M | $-41M | $-63M | $-39M | $-33M | $-28M | $-35M | $-34M | $-8M | |
| EPS (Basic) | $-0.41 | $-0.57 | $-0.57 | $-0.53 | $-0.44 | $-0.40 | $-0.40 | $-0.37 | $-0.48 | $-0.75 | $-0.46 | $-0.40 | $-0.34 | $-0.43 | $-0.40 | $-0.10 | |
| EPS (Diluted) | $-0.41 | $-0.57 | $-0.57 | $-0.53 | $-0.44 | $-0.40 | $-0.40 | $-0.37 | $-0.48 | $-0.75 | $-0.46 | $-0.40 | $-0.34 | $-0.43 | $-0.40 | $-0.10 | |
| Shares (Basic) | 80,050,518 | 79,198,204 | · | 79,052,154 | 83,747,335 | 85,159,254 | · | 84,422,000 | 84,253,700 | 83,916,193 | · | 83,399,769 | 83,399,377 | 83,332,397 | · | 83,258,537 | |
| Shares (Diluted) | 80,050,518 | 79,198,204 | · | 79,052,154 | 83,747,335 | 85,159,254 | · | 84,422,000 | 84,253,700 | 83,916,193 | · | 83,399,769 | 83,399,377 | 83,332,397 | · | 83,258,537 | |
| EBITDA | $-35M | $-48M | · | $-46M | $-41M | $-39M | · | $-37M | $-47M | $-70M | · | $-41M | $-35M | $-42M | · | $-16M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77M | $79M | $96M | $77M | $88M | $119M | $65M | $98M | $243M | $161M | $144M | $138M | $214M | $183M | $188M | $176M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Prepaid Expense | $9M | $7M | $9M | $7M | $6M | $8M | $8M | $4M | $4M | $7M | $12M | $8M | $13M | $12M | $14M | $12M | |
| Current Assets | $229M | $263M | $311M | $336M | $386M | $434M | $462M | $487M | $506M | $549M | $590M | $603M | $621M | $632M | $661M | $682M | |
| PP&E (Net) | $249.0K | $353.0K | $457.0K | $561.0K | $665.0K | $769.0K | $873.0K | $977.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $1M | · | · | · | $689.0K | · | · | · | $273.0K | · | |
| Other Non-current Assets | $3M | $3M | $3M | $5M | $4M | $4M | $197.0K | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | · | |
| Total Assets | $232M | $267M | $315M | $343M | $392M | $440M | $465M | $491M | $510M | $553M | $595M | $608M | $626M | $638M | $667M | $687M | |
| Accounts Payable | $10M | $9M | $13M | $4M | $9M | $7M | $4M | $6M | $5M | $21M | $4M | $395.0K | $4M | $700.0K | $3M | $1M | |
| Current Liabilities | $28M | $33M | $40M | $20M | $20M | $22M | $19M | $25M | $27M | $41M | $32M | $19M | $16M | $12M | $18M | $16M | |
| Capital Leases | · | · | $0 | $213.0K | $425.0K | $634.0K | $842.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Total Liabilities | · | · | $40M | $27M | $27M | $29M | $26M | $32M | $34M | $49M | $40M | $26M | $24M | $20M | $26M | $23M | |
| Common Stock | $80.0K | $80.0K | $78.0K | $78.0K | $81.0K | $85.0K | $84.0K | $84.0K | $84.0K | $84.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | |
| Paid-in Capital | $805M | $802M | $798M | $793M | $800M | $809M | $803M | $788M | $776M | $763M | $751M | $739M | $726M | $714M | $701M | $689M | |
| Retained Earnings | $-601M | $-568M | $-523M | $-478M | $-436M | $-398M | $-364M | $-331M | $-300M | $-259M | $-196M | $-157M | $-124M | $-95M | $-60M | $-25M | |
| AOCI | $-96.0K | $-97.0K | $174.0K | $238.0K | $37.0K | $118.0K | $233.0K | $641.0K | $-280.0K | $-181.0K | $207.0K | $-262.0K | $-310.0K | $-307.0K | $-684.0K | $-855.0K | |
| Stockholders' Equity | $204M | $234M | $275M | $316M | $364M | $411M | $439M | $459M | $476M | $504M | $555M | $582M | $602M | $618M | $641M | $663M | |
| Liabilities + Equity | $232M | $267M | $315M | $343M | $392M | $440M | $465M | $491M | $510M | $553M | $595M | $608M | $626M | $638M | $667M | $687M | |
| Shares Outstanding | 80,204,699 | 80,027,099 | 78,126,796 | 78,126,796 | 81,137,478 | 85,579,475 | 84,463,059 | 84,463,059 | 84,422,000 | 84,223,100 | 83,435,513 | 83,435,513 | 83,399,377 | 83,399,377 | 83,287,639 | 83,287,639 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $106.0K | |
| Stock-based Comp | $3M | $4M | $5M | $5M | $5M | $7M | $14M | $12M | $13M | $13M | $12M | $12M | $12M | $13M | $12M | $12M | |
| Operating Cash Flow | $-37M | $-46M | $-28M | $-40M | $-33M | $-31M | $-30M | $-23M | $-42M | $-40M | $-22M | $-18M | $-16M | $-30M | $-22M | $-21M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $20.0K | |
| Investing Cash Flow | $34M | $30M | $47M | $41M | $15M | $86M | $-3M | $-122M | $125M | $57M | $28M | $-59M | $47M | $24M | $33M | $-487M | |
| Stock Repurchased | · | · | $0 | $11M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | $257.0K | $0 | $-11M | $-14M | $-347.0K | $0 | $117.0K | $0 | $150.0K | $0 | $92.0K | $0 | $165.0K | $0 | $147.0K | |
| Net Change in Cash | $-3M | $-16M | $18M | $-10M | $-32M | $55M | $-34M | $-145M | $82M | $17M | $6M | $-76M | $30M | $-5M | $12M | $-508M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.6% | -12.8% | · | -10.1% | -8.2% | -6.9% | · | -5.7% | -7.1% | -10.6% | · | -5.1% | -4.3% | -5.2% | · | -1.1% | |
| ROE | -11.6% | -14.1% | · | -10.9% | -8.8% | -7.5% | · | -6.0% | -7.5% | -11.2% | · | -5.3% | -4.5% | -5.5% | · | -1.3% | |
| ROIC | -17.2% | -20.6% | · | -14.5% | -11.4% | -9.6% | · | -8.2% | -9.9% | -13.9% | · | -7.1% | -5.9% | -6.8% | · | -1.7% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.1 | 7.9 | · | 16.7 | 19.2 | 19.9 | · | 19.3 | 19.0 | 13.3 | · | 31.9 | 38.4 | 51.2 | · | 43.6 | |
| Quick Ratio | 2.7 | 2.4 | · | 3.8 | 4.4 | 5.5 | · | 3.9 | 9.1 | 3.9 | · | 7.3 | 13.2 | 14.8 | · | 11.6 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.55 | $2.92 | · | $4.04 | $4.49 | $4.80 | · | $5.43 | $5.64 | $5.99 | · | $6.97 | $7.22 | $7.41 | · | $7.96 | |
| Cash Flow / Share | · | $-0.59 | · | · | · | $-0.36 | · | · | · | $-0.48 | · | · | · | $-0.36 | · | · | |
| Cash / Share | $0.95 | $0.99 | · | $0.99 | $1.08 | $1.40 | · | $1.17 | $2.88 | $1.91 | · | $1.65 | $2.56 | $2.20 | · | $2.12 | |
| EPS (TTM) | $-2.08 | $-2.11 | · | $-1.77 | $-1.61 | $-1.65 | · | $-2.06 | $-2.09 | $-1.95 | · | $-1.57 | $-1.27 | $-1.31 | · | $0.36 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $351M | $351M | · | $351M | $351M | $351M | · | $351M | $351M | $351M | · | $351M | $351M | $351M | · | $351M | |
| Net Income TTM | $-165M | $-170M | · | $-147M | $-136M | $-139M | · | $-174M | $-176M | $-164M | · | $-131M | $-106M | $-109M | · | $36M | |
| Market Cap | $373M | $431M | · | $227M | $292M | $256M | · | $283M | $279M | $340M | · | $250M | $312M | $279M | · | $474M | |
| P/E | -2.2 | -2.5 | · | -1.6 | -2.2 | -1.8 | · | -1.6 | -1.6 | -2.1 | · | -1.9 | -2.9 | -2.6 | · | 15.8 | |
| P/S | 1.1 | 1.2 | · | 0.6 | 0.8 | 0.7 | · | 0.8 | 0.8 | 1.0 | · | 0.7 | 0.9 | 0.8 | · | 1.3 | |
| P/B | 1.8 | 1.8 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | |
| P / Tangible Book | 1.8 | 1.8 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | |
| P / Cash Flow | · | -9.3 | · | · | · | -8.4 | · | · | · | -8.5 | · | · | · | -9.4 | · | · | |
| Earnings Yield | -44.7% | -39.2% | · | -61.0% | -44.7% | -55.2% | · | -61.5% | -63.1% | -48.3% | · | -52.3% | -34.0% | -39.1% | · | 6.3% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | · | · | · | · | $351M |
| Operating Margin % | · | · | · | · | 39.4% |
| Net Income | $-158M | $-168M | $-136M | $-116M | $121M |
| Diluted EPS | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.37 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 7.8 | 24.9 | 18.2 | 35.8 | 13.6 |
| Quick Ratio | 2.4 | 3.5 | 4.4 | 10.2 | 13.4 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | · | · | $-123M | $-87M |
Institutional owners (13F) 131 filers · $285.7M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
131
Value held
$285.7M
New positions
19
Exited positions
20
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 19 (-10 vs prior Q) | 20 (+12 vs prior Q) | 45 (+7 vs prior Q) | 39 (+1 vs prior Q) | -619K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| FMR LLC | $55,818,898 | 12,004,064 | 19.54% | Shares |
| BlackRock, Inc. | $40,548,360 | 8,720,077 | 14.20% | Shares |
| BML Capital Management, LLC | $32,328,335 | 6,952,330 | 11.32% | Shares |
| TANG CAPITAL MANAGEMENT LLC | $22,388,355 | 4,814,700 | 7.84% | Shares |
| VANGUARD GROUP INC | $15,090,783 | 4,227,110 | 5.28% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $13,786,608 | 2,964,862 | 4.83% | Shares |
| Bain Capital Life Sciences Investors, LLC | $9,651,721 | 2,075,639 | 3.38% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $9,108,898 | 1,958,435 | 3.19% | Shares |
| STATE STREET CORP | $7,683,655 | 1,652,399 | 2.69% | Shares |
| TWO SIGMA INVESTMENTS, LP | $7,006,141 | 1,506,697 | 2.45% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $6,042,497 | 1,299,515 | 2.12% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $5,260,080 | 1,131,200 | 1.84% | Shares |
| Rosalind Advisors, Inc. | $4,978,058 | 1,070,550 | 1.74% | Shares |
| JPMORGAN CHASE & CO | $4,360,682 | 945,918 | 1.53% | Shares |
| TWO SIGMA ADVISERS, LP | $3,783,129 | 1,059,700 | 1.32% | Shares |
| NORTHERN TRUST CORP | $3,511,862 | 755,239 | 1.23% | Shares |
| MORGAN STANLEY | $3,345,743 | 719,514 | 1.17% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,930,360 | 630,185 | 1.03% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2,839,323 | 610,607 | 0.99% | Shares |
| GOLDMAN SACHS GROUP INC | $2,468,480 | 530,856 | 0.86% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $2,184,575 | 469,801 | 0.76% | Shares |
| CM Management, LLC | $1,650,750 | 355,000 | 0.58% | Shares |
| BARCLAYS PLC | $1,621,239 | 348,653 | 0.57% | Shares |
| D. E. Shaw & Co., Inc. | $1,605,115 | 345,186 | 0.56% | Shares |
| BANQUE PICTET & CIE SA | $1,604,608 | 345,077 | 0.56% | Shares |
| MILLENNIUM MANAGEMENT LLC | $1,416,441 | 304,611 | 0.50% | Shares |
| Nuveen, LLC | $1,321,916 | 284,283 | 0.46% | Shares |
| Invesco Ltd. | $1,242,132 | 267,125 | 0.43% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $1,151,852 | 247,710 | 0.40% | Shares |
| Quantinno Capital Management LP | $1,126,704 | 242,302 | 0.39% | Shares |
| Opaleye Management Inc. | $1,092,750 | 235,000 | 0.38% | Shares |
| HSBC HOLDINGS PLC | $1,023,272 | 221,009 | 0.36% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $979,020 | 210,542 | 0.34% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $961,551 | 206,785 | 0.34% | Shares |
| Bank of New York Mellon Corp | $880,952 | 189,452 | 0.31% | Shares |
| Auour Investments LLC | $823,050 | 177,000 | 0.29% | Shares |
| AMERICAN CENTURY COMPANIES INC | $793,555 | 170,657 | 0.28% | Shares |
| CITADEL ADVISORS LLC | $731,092 | 157,224 | 0.26% | Shares |
| ALLIANCEBERNSTEIN L.P. | $668,304 | 124,220 | 0.23% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $608,685 | 130,900 | 0.21% | Shares |
| STATE OF WISCONSIN INVESTMENT BOARD | $552,220 | 118,757 | 0.19% | Shares |
| STRS OHIO | $547,305 | 117,700 | 0.19% | Shares |
| Jump Financial, LLC | $476,258 | 102,421 | 0.17% | Shares |
| UBS Group AG | $439,457 | 94,507 | 0.15% | Shares |
| RHUMBLINE ADVISERS | $423,720 | 91,124 | 0.15% | Shares |
| Aldebaran Capital, LLC | $410,037 | 88,180 | 0.14% | Shares |
| BANK OF AMERICA CORP /DE/ | $380,044 | 81,730 | 0.13% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $366,053 | 78,721 | 0.13% | Shares |
| DEUTSCHE BANK AG\ | $327,360 | 70,400 | 0.11% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $326,000 | 70,000 | 0.11% | Shares |
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Radoff Family Foundation, Radoff Bradley Louis, JEC II Associates, LLC, The MOS Trust, MOS PTC, LLC, Torok Michael, Berman Howard H., Nerium Partners LP, Nerium Capital LLC, Flynn James P. ×3 filings | April 17, 2025 | 4.00% | Amendment | Board campaign | SEC |
| BML Investment Partners, L.P., Leonard Braden Michael | Dec. 16, 2024 | 8.50% | Initial filing | Passive investment | SEC |
| TANG CAPITAL PARTNERS, LP, TANG CAPITAL MANAGEMENT, LLC, KEVIN TANG, Concentra Biosciences, LLC ×2 filings | Nov. 28, 2023 | · | Initial filing | · | SEC |
| Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, BCLS II Investco, LP ×3 filings | Sept. 24, 2021 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 17 insiders · 6 officers · 11 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jean-Pierre Sommadossi | President, CEO, and Chairman | Feb. 3, 2026 M | 767,830 | 0 | 0 | $0 |
| Andrea Corcoran | Chief Financial Officer, Executive Vice President, Legal and Secretary | March 11, 2026 M | 823,576 | 0 | 0 | $0 |
| Janet Mj Hammond | Chief Development Officer | Jan. 31, 2026 A | 127,665 | 0 | 0 | $0 |
| John Vavricka | Chief Commercial Officer | Jan. 31, 2026 A | 82,594 | 0 | 0 | $0 |
| Maria Arantxa Horga | Chief Medical Officer | Jan. 31, 2026 A | 96,086 | 0 | 0 | $0 |
| Wayne Foster | EVP, Chief Accounting Officer | Jan. 31, 2026 A | 79,329 | 0 | 0 | $0 |
| Berman Howard H. | Director | June 18, 2026 A | · | 0 | 0 | $0 |
| Jerome M. Adams | Director | June 18, 2026 A | 92,350 | 0 | 0 | $0 |
| Bruno Lucidi | Director | June 18, 2026 A | 142,350 | 0 | 0 | $0 |
| Polly A. Murphy | Director | June 18, 2026 A | 121,745 | 2 | 0 | $50,874 |
| Bruce Polsky | Director | June 18, 2026 A | 124,806 | 0 | 0 | $0 |
| Barbara Gayle Duncan | Director | June 18, 2026 A | 92,350 | 0 | 0 | $0 |
| Arthur S Kirsch | Director | June 18, 2026 A | · | 0 | 0 | $0 |
| Franklin M Berger | Director | June 18, 2026 A | 536,097 | 0 | 0 | $0 |
| Andrew A. F. Hack | Director | Nov. 3, 2020 C | 5,615,659 | 0 | 0 | $0 |
| Isaac Cheng | Director | Oct. 29, 2020 A | · | 0 | 0 | $0 |
| Chung K. Chu | · | Nov. 3, 2020 C | 1,176,862 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 23 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.25% | 128,804 SH | Oct. 2, 2026 | Daily |
| IWC · iShares Trust | 0.09% | 239,656 SH | Sept. 11, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.03% | 5,772 SH | Oct. 1, 2026 | Daily |
| IBB · iShares Trust | 0.02% | 487,025 SH | Sept. 11, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 61,782 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 1,801,869 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 33,880 NS | July 31, 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 53,421 SH | Oct. 2, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 408,133 SH | Aug. 19, 2026 | Daily |
| PKW · Invesco Exchange-Traded Fund Trust | 0.01% | 31,628 SH | Oct. 2, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.01% | 263,930 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 8,300 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 181,666 SH | Sept. 11, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.00% | 16,361 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 58,155 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 18,737 SH | Sept. 3, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.00% | 9,202 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 864,902 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2,032,268 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 5,932 SH | Aug. 19, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.00% | 20 NS | July 31, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.00% | 154,338 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 665,401 SH | Sept. 11, 2026 | Daily |
AVIR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 9 analysts
BUY
Median target
$10.00
+94.9%
3 33.3%
Strong Buy
4 44.4%
Buy
2 22.2%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
3 analysts · 2026-10-03Mean target $9.42 +83.6%
← Below all targets
Current price $5.13
Low$7.00
Mean$9.42
High$11.25
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 12, 2026